Yayın:
Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGökhaner, Gökhan
dc.contributor.authorGökhan Gökhaner
dc.contributor.authorZerrin Cantürk
dc.contributor.orcid0009-0000-1090-0166
dc.contributor.orcid0000-0001-7709-4285
dc.date.accessioned2025-11-13T10:50:21Z
dc.date.issued2019-03-03
dc.identifier.doihttps://doi.org/10.1097/cad.0000000000000769
dc.identifier.endpage705
dc.identifier.issn0959-4973
dc.identifier.issue7
dc.identifier.openalexW2920723695
dc.identifier.startpage693
dc.identifier.urihttps://hdl.handle.net/11421/5413
dc.identifier.urihttps://doi.org/10.1097/cad.0000000000000769
dc.identifier.volume30
dc.language.isoen
dc.relation.ispartofAnti-Cancer Drugs
dc.rightsrestrictedAccess
dc.subjectAprepitant
dc.subjectMedicine
dc.subjectPharmacology
dc.subjectCancer research
dc.subjectNausea
dc.subjectAntiemetic
dc.subjectInternal medicine
dc.subject.sdg3
dc.titleEvaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5006654113

Dosyalar

Koleksiyonlar

Publications